Pharmacist Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag ma

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Hospitals

Moving to component management & traceability: progress, barriers, and the way forward

pharmaphorum

SEPTEMBER 30, 2022

The process starts adding fields to regulatory submission templates that will incorporate re-used information, then building templates with standardized structures and including structured data tags and sources. Fillable metadata is next added to the templates. He is a strong proponent of standards and data governance.

Documentation

Documentation Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Moving to component management & traceability: progress, barriers, and the way forward

Stay Connected